Phase I study of intratumoral application of recombinant human tumor necrosis factor.
Pfreundschuh
M G
MG
Medizinische Klinik I, University of Cologne, F.R.G.
Steinmetz
H T
HT
Tüschen
R
R
Schenk
V
V
Diehl
V
V
Schaadt
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use
D014409:Tumor Necrosis Factor-alpha